CRISPR Therapeutics AG
Company Profile
Business description
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for to treat Type 1 diabetes.
Contact
Baarerstrasse 14
Zug CH-6300
CHET: +41 415613277
E: susan.kim@crisprtx.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
407
CRISPR Therapeutics AG News & Analysis
stocks
11 stocks to examine through a sustainability lens
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,243.30 | 19.10 | -0.23% |
| CAC 40 | 7,571.26 | 61.45 | -0.81% |
| DAX 40 | 18,489.15 | 101.74 | -0.55% |
| Dow JONES (US) | 40,211.72 | 210.82 | 0.53% |
| FTSE 100 | 8,140.49 | 42.47 | -0.52% |
| HKSE | 17,727.98 | 287.96 | -1.60% |
| NASDAQ | 18,472.57 | 74.12 | 0.40% |
| Nikkei 225 | 41,275.08 | 84.40 | 0.20% |
| NZX 50 Index | 12,184.49 | 61.35 | 0.51% |
| S&P 500 | 5,631.22 | 0.00 | 0.00% |
| S&P/ASX 200 | 7,999.30 | 18.30 | -0.23% |
| SSE Composite Index | 2,976.30 | 2.29 | 0.08% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Droneshield Ltd DRO | 2.02 | 0.58 | -22.31% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | -2.94% |
| Red 5 Ltd RED | 0.42 | 0.00 | 0.00% |
| Mirvac Group MGR | 2.12 | 0.04 | 1.92% |
| Opthea Ltd OPT | 0.38 | 0.01 | -1.32% |
| Imugene Ltd IMU | 0.06 | 0.00 | -3.51% |
| Telstra Group Ltd TLS | 3.83 | 0.01 | -0.26% |
| Bellevue Gold Ltd BGL | 1.87 | 0.07 | -3.37% |
| Latin Resources Ltd LRS | 0.16 | 0.01 | -5.88% |
| Zip Co Ltd ZIP | 1.61 | 0.03 | 1.90% |